Compare Relay Therapeutics Inc. Common Stock (RLAY) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Relay Therapeutics Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 6.4× Relay Therapeutics Inc. Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (5,738,571 versus 3,432,928). Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| RLAY | ROIV | |
|---|---|---|
Market Cap | $3.94B | $25.09B |
Volume | 3,432,928 | 5,738,571 |
Sector | Health | Health |
52-Week High | $20.75 | $41.81 |
52-Week Low | $6.03 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.06B | $21.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
